3. Antimycobacterials Flashcards
M. tuberculosis Prophylaxis
Isoniazid
M. tuberculosis Treatment
Rifampin
Isoniazid
Pyrazinamide
Ethambutol
“RIPE for treatment”
M. avium intracellulare Prophylaxis
Azithromycin
M. avium intracellulare Treatment
Azithromycin
Rifampin
Ethambutol
Streptomycin
M. leprae Prophylaxis
NONE
M. leprae Treatment
Dapsone
Rifampin
Clofazimine
Isoniazid (INH) - MOA
- Decrease synthesis of mycolic acids
- Bacterial catalase-peroxidase required to convert INH to active metabolite.
Isoniazid (INH) - Clinical Use
- MYCOBACTERIUM TUBERCULOSIS treatment and prophylaxis
Isoniazid (INH) - Toxicities
- Nephrotoxicity, hepatotoxicity, lupus
- Pyridoxine (Vit. B6) can prevent neurotoxicity, lupus.
“INH - Injures Neurons and Hepatocytes”
Different INH half lives in fast and slow acetylators
Rifampin - MOA
- Inhibit DNA dependent RNA polymerase.
“Rifampin’s 4 R’s
- RNA polymerase inhibitor
- Revs up microsomal p450
- Red / orange body fluids
- Rapid resistance if used alone”
Rifampin - Clinical Use
- MYCOBACTERIUM TUBERCULOSIS treatment
- Delays resistance to Dapsone when used for leprosy.
- Prophylaxis for meningococcal infections
- Prophylaxis for contacts of H. influenzae type B
Rifampin - Toxicities
- Minor hepatotoxicity and drug interactions (Increase p450 activity)
- Orange body fluids (non-toxic)
- Rapid resistance if used alone
“Rifampin’s 4 R’s
- RNA polymerase inhibitor
- Revs up microsomal p450
- Red / orange body fluids
- Rapid resistance if used alone”
Pyrazinamide - MOA
Uncertain
- May acidify intracellular environment by conversion to Pyrazanoic acid
Pyrazinamide - Clinical Use
- Mycobacterium tuberculosis treatment
Pyrazinamide - Toxicities
Hyperuricemia
Hepatotoxicity